Defense World
19 Jul 2026, 08:17 UTC · 10w ago
Verdict
Headline takes no side. We score XRAY −0.20 across five claims — slightly bearish.
−0.20slightly bearish
More negative than 62% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Multiple major investment firms, including Barclays and Citigroup, have issued 'underweight' or 'sell' ratings with price targets as low as $9.00 and $10.00.
More negative than 94% of claims this week
Dentsply Sirona directors Michael J. Barber and Brian P. Mckeon purchased a combined 25,175 shares in June 2026.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 79% of claims this week
The company's most recent quarterly EPS of $0.27 missed the analyst consensus estimate of $0.28.
More negative than 68% of claims this week
Institutional investors, including First Eagle Investment Management and Invenomic Capital Management, have recently increased their holdings in the company.
More positive than 54% of claims this week
Dentsply Sirona has set its FY 2026 EPS guidance between $1.40 and $1.50.
More positive than 46% of claims this week
Which stocks this story touches
More negative than 62% of ticker scores this week
Despite insider buying and institutional interest, the company faces multiple 'sell' or 'underweight' ratings, price target cuts, and an earnings miss.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Globe News Wire
2h ago
−36.1%
Price agrees with the score
$8.98 vs $14.05 close before publication (Jul 17) · not market-adjusted
XRAY chart →
